Company news
United Laboratories International Holdings Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2026
November 5, 2026
The group's product Semaglutide Injection marketing registration application been accepted
November 4, 2026
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2026
October 4, 2026
Second milestone payment from novo for exclusive license agreement of UBT251
September 24, 2026
Notification Letter to Non-register Holder and Reply Form
September 24, 2026
Notification Letter to Shareholder and Reply Form
September 24, 2026
2026 Interim report
September 24, 2026
The group's product insulin degludec and liraglutide injection marketing registration application been accepted
September 24, 2026
United Laboratories International Holdings: General mandates to issue securities and repurchase shares, re-election of directors and notice of annual general meeting
April 29, 2021
Redemption notice
August 17, 2020
United Laboratories International Holdings: U.S.$130,000,000 convertible bonds due 2021 adjustment to conversion price of the bonds
July 24, 2020
Loan facility with china everbright bank - announcement pursuant to rule 13.18 of the listing rules
February 20, 2020
United Laboratories International Holdings: Loan facilities - announcement pursuant to rule 13.18 of the listing rules
November 8, 2019
Loan facility with china development bank - announcement pursuant to rule 13.18 of the listing rules
October 23, 2019